Nafarelin
Nafarelin (pronounced na-fa-REL-in) is a type of gonadotropin-releasing hormone (GnRH) agonist. It is a synthetic form of GnRH used primarily in the treatment of endometriosis and central precocious puberty.
Etymology
The term "Nafarelin" is derived from the chemical name Nafarelin acetate, which is a decapeptide. It is a modified form of the naturally occurring gonadotropin-releasing hormone (GnRH).
Usage
Nafarelin is used to manage endometriosis, a condition where the tissue that normally lines the uterus grows in other parts of the body. It is also used to treat central precocious puberty, a condition causing children to enter puberty too soon.
Mechanism of Action
Nafarelin works by decreasing the amount of certain hormones in the body including estrogen in women and testosterone in men. This effect helps to reduce symptoms such as pain in endometriosis and slows down early puberty in children.
Related Terms
- Gonadotropin-releasing hormone
- Agonist
- Endometriosis
- Central precocious puberty
- Estrogen
- Testosterone
See Also
External links
- Medical encyclopedia article on Nafarelin
- Wikipedia's article - Nafarelin
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski